Camgenium, a leading medical software engineering company, has announced further details of its partnership with MedTech innovator Cardiac Tech to develop and deploy its new medical device product, Pace-Protect. The companies say this medical device has the potential to significantly improve patient
Dxcover Limited, a clinical-stage diagnostics company pioneering its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumour cancers, has announced the presentation of real-world data showing, for the first time, a clear and consistent association between increased tumour size and
IXI, a company which it says it is on a mission to change how the world sees with the first autofocus glasses, has raised 36.5 million USD in Series A funding. The round was led by Plural, with participation from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer and IXI’s existi
Leica Microsystems, a leading provider of microscopy and scientific instrumentation, has launched Proveo 8x, a 3D digital ophthalmic microscope with real-time 3D imaging, at the Annual Meeting of The American Society of Cataract and Refractive Surgery (ASCRS) in California, USA. Attendees discovered
PacBio, a leading provider of high-quality, highly accurate sequencing platforms, has announced it plans to improve on its already highly accurate methylation detection capabilities in HiFi chemistry through licensing advanced DNA methylation detection methods developed by Professor Dennis Lo and co
OSSTEC, a London-based start-up changing the face of joint replacement implants with a novel 3D printing technology, has raised 2.5 million GBP in funding. The round was led by specialist DeepTech VC Empirical Ventures, which, due to increased interest, remains open for further investment. Osteoart
Medtronic has announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync sensor for use with the MiniMed 780G system. With this approval, the MiniMed 780G system now offers more flexibility for users of the company’s most advanced insulin delivery system featuring Meal Dete
42 Technology (42T) is helping Cambridge University Hospitals NHS Foundation Trust (CUH) to develop an advanced AI feature for a ‘groundbreaking’ hand-held newborn eye screening device. This innovation aims to further improve the accuracy of diagnosing congenital cataracts – the leading cause of avo
Skin Analytics raises £15M to expand AI skin cancer detection globally following CE mark for autonomous diagnosis. Now entering new markets beyond the UK.
Accumold, A specialist in micro moulding for medical devices will present its latest innovations at MD&M East 2025 in New York City, from 20–22 May. Visitors to Booth 551 can explore how advanced moulding techniques are enabling smaller, smarter medical components. With over 40 years of experience,
Anaconda Biomed, S.L. has announced that results of the ANAIS Study, which evaluated the safety and performance of its ANA funnel catheter in the endovascular treatment of large vessel occlusion acute ischemic stroke, have been published in the American Journal of Neuroradiology. The data demonstrat
Anaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, has announced the enrolment and treatment of the first U.S. patient in its ATHENA clinical trial by Shahram Majidi, MD, Associate Professor of Neurosurgery, Neurology, and Radiology at Icahn Sch
